Drugs / NI-071
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01931189 | Aug 2013 → Jan 2014 | — | Nichi-Iko Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02990806 | Jan 2017 → May 2019 | rheumatoid arthritis | Nichi-Iko Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT01927263 | Jul 2013 → Mar 2015 | rheumatoid arthritis | Nichi-Iko Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NI-071 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01931189 ↗ |
| Route | Intravenous | “IV infusion.” NCT02990806 ↗ |